ArticleJournal of the International AIDS Society2019
Reaching and targeting more effectively: the application of market segmentation to improve HIV prevention programmes.
Article in Journal of the International AIDS Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06803316 (Optimizing Care Delivery to Support Reengagement in PLWH Returning to HIV Care After Treatment Lapses in Zambia), which is not on this map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Optimizing Care Delivery to Support Reengagement in PLWH Returning to HIV Care After Treatment Lapses in Zambia
Who cites it
17 citing papers in PubMed.
- Innovative demand creation strategies to increase voluntary medical male circumcision uptake: a pragmatic randomised controlled trial in Zimbabwe.BMJ global health · 2021Trial
- Exploring adolescent girls and young women's PrEP-user profiles: qualitative insights into differentiated PrEP delivery platform selection and engagement in Cape Town, South Africa.Journal of the International AIDS Society · 2024Article
- "Youth are experts in what they need": experiences and best practice in co-designing and implementing Fast-PrEP, a novel PrEP service for adolescents and youth in Cape Town, South Africa.Frontiers in public health · 2024Article
- Awareness of and willingness to use oral pre-exposure prophylaxis (PrEP) for HIV prevention among sexually active adults in Malawi: results from the 2020 Malawi population-based HIV impact assessment.BMC infectious diseases · 2023Article
- Personalization: a new political arithmetic?Distinktion : Scandinavian journal of social theory · 2023Article
- How might we motivate uptake of the Dual Prevention Pill? Findings from human-centered design research with potential end users, male partners, and healthcare providers.Frontiers in reproductive health · 2023Article
- Defining the Global Research and Programmatic Agenda and Priority Actions for Voluntary Medical Male Circumcision for HIV Prevention.Current HIV/AIDS reports · 2022Review
- HIV prevention for the next decade: Appropriate, person-centred, prioritised, effective, combination prevention.PLoS medicine · 2022Article
- Turning the tide in HIV through health communication research.Journal of the International AIDS Society · 2022Article
- Girl Champ in eSwatini: A Strategic Marketing Campaign to Promote Demand for Sexual and Reproductive Health Services Among Young Women.AIDS and behavior · 2022Article
- Health system adaptations and considerations to facilitate optimal oral pre-exposure prophylaxis scale-up in sub-Saharan Africa.The lancet. HIV · 2021Review
- Article
- Introduction to series on technology-based HIV prevention and care interventions for youth.mHealth · 2021Article
- Creating HIV risk profiles for men in South Africa: a latent class approach using cross-sectional survey data.Journal of the International AIDS Society · 2020Article
- PrEP Product Acceptability and Dual Process Decision-Making Among Men Who Have Sex with Men.Current HIV/AIDS reports · 2020Review
- Maximizing the impact of HIV prevention technologies in sub-Saharan Africa.Journal of the International AIDS Society · 2019Article
- Reaching and targeting more effectively: the application of market segmentation to improve HIV prevention programmes.Journal of the International AIDS Society · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.